Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest University of California, Los Angeles Stories

2013-03-27 12:28:47

Science Matters Program Explores the Scientific and Social Impact of Medical Marijuana Presented by the California Science Center LOS ANGELES, March 27, 2013 /PRNewswire-USNewswire/ -- The California Science Center's Science Matters, a speaker's program that explores science issues in the forefront of public concern, will present "Medical Marijuana: Helpful or Harmful?" March 30, 2013 from 1:00-2:30 p.m. The program is free to the public and will take place in the Loker Conference...

2013-02-20 12:25:15

LOS ANGELES, Feb. 20, 2013 /PRNewswire/ -- Following last year's successful collaboration, UCLA Anderson School of Management is again partnering with TED - the nonprofit that presents the globally acclaimed TED (Technology, Entertainment, and Design) conferences - to host a series of panels, TEDActive workshops and TED-themed talks on campus from Tuesday, Feb. 26 to Thursday, Feb. 28. The multi-day event drew roughly 900 attendees in its 2012 debut. TED Week 2013 will offer the UCLA...

2013-02-11 04:20:41

LOS ANGELES, Feb. 11, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that Christopher DeGiorgio, M.D., Vice President of Neurology at NeuroSigma and Professor of Neurology at the University of California, Los Angeles (UCLA), and Colin Kealey, M.D., Manager of Business Development at NeuroSigma, will present in London, an overview of external trigeminal nerve stimulation (eTNS(TM)) for the treatment of epilepsy and depression at The Royal...

2013-02-04 08:25:15

LOS ANGELES, Feb. 4, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced it received a Notice of Award, for a Fast Track Small Business Innovation Research (SBIR) grant, from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH). Phase I of the project is budgeted in the amount of $600,000, with $3 Million budgeted for Phase II, subject to the availability of funds and satisfactory progress...

2013-01-30 20:22:15

LOS ANGELES, Jan. 30, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced the publication of a positive Phase II clinical study for the use of external Trigeminal Nerve Stimulation (eTNS(TM)) for the treatment of drug-resistant epilepsy. The study, led by Christopher M. DeGiorgio, M.D., Professor of Neurology at the University of California, Los Angeles (UCLA) and Vice President of Neurology at NeuroSigma, was published online in the January 30,...

2013-01-25 12:25:38

LOS ANGELES, Jan. 25, 2013 /PRNewswire/ -- Heritage Provider Network, Inc., The University of California Los Angeles (UCLA) and Open mHealth today announced the launch of a $100,000 mobile apps health prize challenge. (Logo: http://photos.prnewswire.com/prnh/20120418/LA89605LOGO-a) The Heritage Open mHealth challenge will encourage teams to create mobile applications using the Open mHealth architecture. The use of an open architecture overcomes inherent limitations created by dissimilar...

2013-01-24 20:22:03

LOS ANGELES, Jan. 24, 2013 /PRNewswire/ -- UCLA Anderson School of Management has teamed up with three other UC schools to offer an executive training program that helps diverse business enterprises (DBEs) meet the changing technological needs of their customers. The first group of participants in the Advanced Technology Management Institute (ATMI), which launched in 2012, will complete its final program module on Jan. 26. "Entrepreneurs in emerging growth companies will find that programs...

Brain-imaging Tool Used To Identify Concussion-related Abnormal Brain Proteins In Retired NFL Players
2013-01-22 15:04:06

University of California - Los Angeles Health Sciences Technique may lead to earlier diagnosis, tracking of brain disorders in athletes Sports-related concussions and mild traumatic brain injuries have grabbed headlines in recent months, as the long-term damage they can cause becomes increasingly evident among both current and former athletes. The Centers for Disease Control and Prevention estimates that millions of these injuries occur each year. Despite the devastating consequences...

2013-01-22 08:29:46

LOS ANGELES, Jan. 22, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California -based medical device company, announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application No. 12/898,686 entitled "Devices, Systems and Methods For Treatment of Neuropsychiatric Disorders." The patent application, exclusively licensed to NeuroSigma, is owned by The Regents of the University of California (Regents) as a result of research conducted by...

2013-01-14 20:21:14

LOS ANGELES, Jan. 14, 2013 /PRNewswire/ -- The Thirty-Seventh UCLA Entertainment Symposium, "Deals on the Edge," will welcome several hundred participants on March 8-9, 2013, at UCLA's Freud Playhouse, Macgowan Hall. The annual event addresses subjects at the forefront of the entertainment industry. The Symposium features leading entertainment industry executives who will share their perspectives on the status of the industry and the impact of evolving technologies on deal making and...


Latest University of California, Los Angeles Reference Libraries

Anna Fisher
2012-09-05 10:20:17

Anna Fisher is an American chemist and a NASA astronaut. She was born Anna Lee Tingle on August 24, 1949 in New York City. She grew up in San Pedro, California and graduated from San Pedro High School in 1967. She went on to attend the University of California Los Angeles, where she received a Bachelor of Science in Chemistry in 1971. Fisher remained at UCLA to start graduate school in chemistry, focusing on x-ray crystallographic studies, and received her Doctorate of Medicine in 1976.  The...

More Articles (1 articles) »